Bone marrow transplants for severe aplastic anemia (1970s)
Transplant teams began replacing failing marrow in severe aplastic anemia patients with bone marrow from matched living relatives and, later, unrelated donors. The procedure turned a usually fatal diagnosis into one with a curative option.
Bone marrow became the standard graft for non-malignant marrow failure, chosen partly because it carries fewer immune cells than peripheral blood stem cells.
The procedure's limitation shifted from technique to supply: a matching living donor still had to be found and undergo a surgical collection.
The technique in this case is decades old. What is new is where the marrow came from, which addresses the supply constraint rather than the procedure itself.
